IRIS Accounts Production v23.3.0.418 13499868 Board of Directors 1.8.22 31.7.23 31.7.23 false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh134998682022-07-31134998682023-07-31134998682022-08-012023-07-31134998682021-07-07134998682021-07-082022-07-31134998682022-07-3113499868ns10:Originalns15:EnglandWales2022-08-012023-07-3113499868ns14:PoundSterlingns10:Original2022-08-012023-07-3113499868ns10:Originalns10:Director12022-08-012023-07-3113499868ns10:Original2022-08-012023-07-3113499868ns10:Original2023-07-3113499868ns10:Originalns10:PrivateLimitedCompanyLtd2022-08-012023-07-3113499868ns10:Originalns10:SmallEntities2022-08-012023-07-3113499868ns10:Originalns10:AuditExempt-NoAccountantsReport2022-08-012023-07-3113499868ns10:Originalns10:SmallCompaniesRegimeForDirectorsReport2022-08-012023-07-3113499868ns10:SmallCompaniesRegimeForAccountsns10:Original2022-08-012023-07-3113499868ns10:Originalns10:FullAccounts2022-08-012023-07-3113499868ns10:Original2022-07-3113499868ns10:Originalns5:CurrentFinancialInstruments2023-07-3113499868ns10:Originalns5:CurrentFinancialInstruments2022-07-3113499868ns5:ShareCapitalns10:Original2023-07-3113499868ns5:ShareCapitalns10:Original2022-07-3113499868ns10:Originalns5:RetainedEarningsAccumulatedLosses2023-07-3113499868ns10:Originalns5:RetainedEarningsAccumulatedLosses2022-07-3113499868ns10:Originalns10:RegisteredOffice2022-08-012023-07-3113499868ns10:Original2021-07-082022-07-3113499868ns10:Originalns5:CurrentFinancialInstrumentsns5:WithinOneYear2023-07-3113499868ns10:Originalns5:CurrentFinancialInstrumentsns5:WithinOneYear2022-07-31
REGISTERED NUMBER: 13499868 (England and Wales)















4 MEDICAL TESTING LIMITED

UNAUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 JULY 2023






4 MEDICAL TESTING LIMITED (REGISTERED NUMBER: 13499868)

CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 JULY 2023










Page

Balance Sheet 1

Notes to the Financial Statements 2


4 MEDICAL TESTING LIMITED (REGISTERED NUMBER: 13499868)

BALANCE SHEET
31 JULY 2023

2023 2022
Notes £    £   
Current assets
Stocks 1,800 3,700
Debtors 4 1,201 5,572
Cash at bank 750 30,949
3,751 40,221
Creditors
Amounts falling due within one year 5 (740 ) (43,910 )
Net current assets/(liabilities) 3,011 (3,689 )
Total assets less current liabilities 3,011 (3,689 )

Capital and reserves
Called up share capital 100 100
Retained earnings 2,911 (3,789 )
3,011 (3,689 )

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 July 2023.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 July 2023 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 6 March 2024 and were signed on its behalf by:





Mr Nasim Akhtar Patel - Director


4 MEDICAL TESTING LIMITED (REGISTERED NUMBER: 13499868)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 JULY 2023


1. Statutory information

4 Medical Testing Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address are as below:

Registered number: 13499868

Registered office: M60 Office Park Suite A, Beech Court, Wy
Swinton
Manchester
Lancashire
M27 8FF

2. Accounting policies

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Hire purchase and leasing commitments
Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

3. Employees and directors

The average number of employees during the year was 4 (2022 - 4 ) .

4 MEDICAL TESTING LIMITED (REGISTERED NUMBER: 13499868)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 JULY 2023


4. Debtors: amounts falling due within one year
2023 2022
£    £   
Trade debtors - 3,967
Other debtors 1,201 1,605
1,201 5,572

5. Creditors: amounts falling due within one year
2023 2022
£    £   
Trade creditors - 2,160
Other creditors 740 41,750
740 43,910

6. Related party disclosures

During the period, loans from related party 4 Medical Clinical Solutions Ltd were written off to the value of £53,510.